Can siRNA Improve Compliance in Patients With Hypertension?

Patients achieve a reduction in systolic blood pressure of >15 mm Hg for as long as 8 weeks after administration of a single dose of zilebesiran.

Related Keywords

Paris ,France General ,France ,French ,Michel Azizi ,Alnylam Pharmaceuticals ,Georges Pompidou European Hospital ,International Meeting ,French Society ,Hypertension ,Increased Blood Pressure ,Uncontrolled Hypertension ,Adherence ,Dherence To Medication Issues For Patients ,Cv ,Ardiovascular ,Lipids ,Ipid Management ,Hypotension ,Liver ,Amyloidosis ,Antihypertensive ,Diet ,Europe ,European ,Hospitals ,Hypercholesterolemia ,Kidneys ,Low Ldl Cholesterol ,Ypobetalipoproteinemia ,Ow Low Density Lipoprotein Cholesterol ,Renal Denervation ,Dr ,